BAG3 and diabetes mellitus: Moreover, in our in vivo preclinical model of PAD with diabetes, ischemic diabetic GAs showed less BAG3 expression and higher expression of necroptosis markers, whereas overexpression of BAG3 in ischemic diabetic GAs resulted in lower expression of necroptosis markers.